Ruskinn's core business is the development and manufacture of sealed Hypoxic (low O2) and Anoxic (zero O2) "glove port" workstations for cell biology, stem cell research and microbiology applications. Until now, Ruskinn has sold its products for research applications primarily in universities and hospitals. Now a new market in cell culture manufacturing in accordance with Good Manufacturing Practices (GMP) is emerging. The innovation explored in this feasibility study is to evaluate an integrated platform which will yield massive cost reduction and also a Hypoxic environment.

Ruskinn's core business is the development and manufacture of sealed Hypoxic (low O2) and Anoxic (zero O2) "glove port" workstations for cell biology, stem cell research and microbiology applications. Until now, Ruskinn has sold its products for research applications primarily in universities and hospitals. Now a new market in cell culture manufacturing in accordance with Good Manufacturing Practices (GMP) is emerging. The innovation explored in this feasibility study is to automate decontamination with a defined and repeatable protocol. As an adjunct, methods for preventing mitigating cross-contamination between cell cultures will also be explored.

Ruskinn's core business is the development and manufacture of sealed Hypoxic (low Oxygen) and Anaerobic (zero Oxygen) "glove port" workstations for cell biology and microbiology applications, including stem cell research. This Feasibility Study explores a new Oxygen sensing technology and related systems which will cause a disruptive performance shift in the workstation marketplace.

Ruskinn is a UK based manufacturer of gas and temperature controlled workstations for cell biology and microbiology applications. These workstations are exported worldwide and generally used in biology research labs. Ruskinn is currently developing a new application for conditioning of cell growth media. The purpose of this feasiblity study is to explore a fundamental and innovative change to the gas mixer to enable a disruptive cost without affecting the required performance.